Nociceptin/orphanin FQ suppresses the excitability of neurons in the ventromedial nucleus of the hypothalamus

Journal of Physiology

Volumn 589, Issue 13, 2011, Pages 3103-3114

  Chee, Melissa J ^a   Price, Christopher J ^a   Statnick, Michael A ^b   Colmers, William F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 [4 (2,6 DICHLOROPHENYL) 1 PIPERIDINYLMETHYL] 6,7,8,9 TETRAHYDRO 1 METHYL 5H BENZOCYCLOHEPTEN 5 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BACLOFEN; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; GUANINE NUCLEOTIDE BINDING PROTEIN; LEPTIN RECEPTOR; NOCICEPTIN; NOCICEPTIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC ACCIDENT; ENERGY; ENERGY BALANCE; FOOD INTAKE; HOMEOSTASIS; HYPERPOLARIZATION; HYPOTHALAMUS; MALE; MEMBRANE POTENTIAL; MOUSE; NERVE CELL INHIBITION; NERVE EXCITABILITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WHOLE CELL; ZONA INCERTA;

ACTION POTENTIALS; ANIMALS; CYCLOHEPTANES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; OPIOID PEPTIDES; PIPERIDINES; RECEPTORS, LEPTIN; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 79959733112     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.208819     Document Type: Article

References (51)

1. Beedle AM, McRory JE, Poirot O, Doering CJ, Altier C, Barrere C, Hamid J, Nargeot J, Bourinet E & Zamponi GW (2004). Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci 7, 118-125.
2. Bingham NC, Anderson KK, Reuter AL, Stallings NR & Parker KL (2008). Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology 149, 2138-2148.
3. Bomberg EM, Grace MK, Levine AS & Olszewski PK (2006). Functional interaction between nociceptin/orphanin FQ and α-melanocyte-stimulating hormone in the regulation of feeding. Peptides 27, 1827-1834.
4. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M & Grandy DK (1994). Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type. FEBS Lett 347, 284-288.
5. Chee MJ, Morl K, Lindner D, Merten N, Zamponi GW, Light PE, Beck-Sickinger AG & Colmers WF (2008). The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptor. J Biol Chem 283, 33337-33346.
6. Chee MJ, Myers MG Jr, Price CJ & Colmers WF (2010). Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus. J Neurosci 30, 3380-3390.
7. Davidowa H, Li Y & Plagemann A (2002). Differential response to NPY of PVH and dopamine-responsive VMH neurons in overweight rats. Neuroreport 13, 1523-1527.
8. Davis AM, Seney ML, Stallings NR, Zhao LP, Parker KL & Tobet SA (2004). Loss of steroidogenic factor 1 alters cellular topography in the mouse ventromedial nucleus of the hypothalamus. J Neurobiol 60, 424-436.
9. Dellovade TL, Young M, Ross EP, Henderson R, Caron K, Parker K & Tobet SA 2000. Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes. J Comp Neurol 423, 579-589.
10. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V, Kenny CD, Christiansen LM, White RD, Edelstein EA, Coppari R, Balthasar N, Cowley MA, Chua S Jr, Elmquist JK & Lowell BB (2006). Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191-203.
11. Emmerson PJ & Miller RJ (1999). Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro. J Physiol 517, 431-445.
12. Evans RM, You H, Hameed S, Altier C, Mezghrani A, Bourinet E & Zamponi GW (2010). Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation. J Biol Chem 285, 1032-1040.
13. Gehlert DR, Gackenheimer SL & Shaw JL (2006). Distribution of nociceptin and Ro64-6198 activated [35S]-GTPγS binding in the rat brain. Neuropeptides 40, 95-105.
14. Gosnell BA, Levine AS & Morley JE (1986a). The stimulation of food intake by selective agonists of μ, κ and δ opioid receptors. Life Sci 38, 1081-1088.
15. Gosnell BA, Morley JE & Levine AS (1986b). Opioid-induced feeding: localization of sensitive brain sites. Brain Res 369, 177-184.
16. Gulati K (1995). Differential effects of intrahypothalamic administration of opioids on food intake in naive and tolerant rats. Pharmacol Biochem Behav 52, 689-694.
17. Hetherington AW & Ranson SW (1940). Hypothalamic lesions and adiposity in the rat. Anat Rec 78, 149-172.
18. Ikeda Y, Luo X, Abbud R, Nilson JH & Parker KL (1995). The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 9, 478-486.
19. Kumarnsit E, Johnstone LE & Leng G (2003). Actions of neuropeptide Y and growth hormone secretagogues in the arcuate nucleus and ventromedial hypothalamic nucleus. Eur J Neurosci 17, 937-944.
20. Kuzhikandathil EV & Oxford GS (2002). Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2, 3, 4, 5-tetrahydro-1H-3-benzaze pine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels. Mol Pharmacol 62, 119-126.
21. Lachowicz JE, Shen Y, Monsma FJ Jr & Sibley DR (1995). Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 64, 34-40.
22. Lee K, Nicholson JR & McKnight AT (1997). Nociceptin hyperpolarises neurones in the rat ventromedial hypothalamus. Neurosci Lett 239, 37-40.
23. Leinninger GM, Jo YH, Leshan RL, Louis GW, Yang H, Barrera JG, Wilson H, Opland DM, Faouzi MA, Gong Y, Jones JC, Rhodes CJ, Chua S Jr, Diano S, Horvath TL, Seeley RJ, Becker JB, Münzberg H & Myers MG Jr (2009). Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 10, 89-98.
24. Leshan RL, Björnholm M, Münzberg H & Myers MG Jr (2006). Leptin receptor signaling and action in the central nervous system. Obesity 14, 208S-212S.
25. Leshan RL, Louis GW, Jo YH, Rhodes CJ, Munzberg H & Myers MG Jr (2009). Direct innervation of GnRH neurons by metabolic- and sexual odorant-sensing leptin receptor neurons in the hypothalamic ventral premammillary nucleus. J Neurosci 29, 3138-3147.
26. + ions in rat sympathetic neurons. Mol Pharmacol 77, 804-817.
27. Majdic G, Young M, Gomez-Sanchez E, Anderson P, Szczepaniak LS, Dobbins RL, McGarry JD & Parker KL (2002). Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 143, 607-614.
28. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P & Monsarrat B (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
29. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G & Meunier JC (1994). ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341, 33-38.
30. 14Tyr]-orphanin FQ binding. J Comp Neurol 412, 563-605.
31. Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O & Watson SJ Jr (1999b). Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 406, 503-547.
32. Olszewski PK, Billington CJ & Levine AS (2000). Fos expression in feeding-related brain areas following intracerebroventricular administration of orphanin FQ in rats. Brain Res 855, 171-175.
33. Olszewski PK & Levine AS (2004). Minireview: Characterization of influence of central nociceptin/orphanin FQ on consummatory behavior. Endocrinology 145, 2627-2632.
34. Olszewski PK & Levine AS (2007). Central opioids and consumption of sweet tastants: when reward outweighs homeostasis. Physiol Behav 91, 506-512.
35. Patterson CM, Leshan RL, Jones JC & Myers MG Jr (2011). Molecular mapping of mouse brain regions innervated by leptin receptor-expressing cells. Brain Res 1378, 18-28.
36. Pietras TA & Rowland NE (2002). Effect of opioid and cannabinoids receptor antagonism on orphanin FQ-induced hyperphagia in rats. Eur J Pharmacol 442, 237-239.
37. Polidori C, de Caro G & Massi M (2000). The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides 21, 1051-1062.
38. Pomonis JD, Billington CJ & Levine AS (1996). Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport 8, 369-371.
39. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr & Civelli O (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270, 792-794.
40. Rizzi A, Gavioli EC, Marzola G, Spagnolo B, Zucchini S, Ciccocioppo R, Trapella C, Regoli D & Calo G (2007). Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2, 6-dichlorophenyl)piperidin-1-yl]methyl]-6, 7, 8, 9 -tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies. J Pharmacol Exp Ther 321, 968-974.
41. Scott MM, Lachey JL, Sternson SM, Lee CE, Elias CF, Friedman JM & Elmquist JK (2009). Leptin targets in the mouse brain. J Comp Neurol 514, 518-532.
42. Shinoda K, Lei H, Yoshii H, Nomura M, Nagano M, Shiba H, Sasaki H, Osawa Y, Ninomiya Y, Niwa O, Morohashi KI & Li E (1995). Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 204, 22-29.
43. B receptor-activated inwardly rectifying potassium current in dissociated hippocampal CA3 neurons. J Neurosci 16, 6374-6385.
44. Sternson SM, Shepherd GM & Friedman JM (2005). Topographic mapping of VMH -> arcuate nucleus microcircuits and their reorganization by fasting. Nat Neurosci 8, 1356-1363.
45. Stratford TR, Holahan MR & Kelley AE (1997). Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport 8, 423-426.
46. Tepperman FS & Hirst M (1982). Concerning the specificity of the hypothalamic opiate receptor responsible for food intake in the rat. Pharmacol Biochem Behav 17, 1141-1144.
47. Torrecilla M, Marker CL, Cintora SC, Stoffel M, Williams JT & Wickman K (2002). G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons. J Neurosci 22, 4328-4334.
48. Tran PV, Lee MB, Marin O, Xu B, Jones KR, Reichardt LF, Rubenstein JR & Ingraham HA (2003). Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons. Mol Cell Neurosci 22, 441-453.
49. + conductance. Neuroendocrinology 67, 73-82.
50. Yirmiya R, Lieblich I & Liebeskind JC (1988). Reduced saccharin preference in CXBK (opioid receptor-deficient) mice. Brain Res 438, 339-342.
51. Zaratin PF, Petrone G, Sbacchi M, Garnier M, Fossati C, Petrillo P, Ronzoni S, Giardina GA & Scheideler MA (2004). Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2, 6-dichlorophenyl)piperidin-1-yl]methyl]-6, 7, 8, 9- tetrahydro-5H-benzocyclohepten-5-ol (SB-612111). J Pharmacol Exp Ther 308, 454-461.